New Key Statistics Module, Z-Score and F-Score
OTCPK:SFOSF Key Ratios
| Market Cap $ M | 8,872.31 |
| Enterprise Value $ M | 14,619.75 |
| P/E(ttm) | 18.48 |
| PE Ratio without NRI | 18.11 |
| Forward PE Ratio | 8.99 |
| Price/Book | 1.32 |
| Price/Sales | 1.52 |
| Price/Free Cash Flow | 72.49 |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.24 |
| Revenue (TTM) $ M | 5,996.00 |
| EPS (TTM) $ | 0.19 |
| Beneish M-Score | -2.44 |
| 10-y EBITDA Growth Rate % | 6.10 |
| 5-y EBITDA Growth Rate % | 3.40 |
| y-y EBITDA Growth Rate % | 7.60 |
| EV-to-EBIT | 15.52 |
| EV-to-EBITDA | 15.52 |
| PEG | 5.33 |
| Shares Outstanding M | 2,670.43 |
| Net Margin (%) | 8.22 |
| Operating Margin % | 7.82 |
| Pre-tax Margin (%) | 12.11 |
| Quick Ratio | 0.76 |
| Current Ratio | 0.93 |
| ROA % (ttm) | 2.91 |
| ROE % (ttm) | 7.21 |
| ROIC % (ttm) | 2.57 |
| Dividend Yield % | 2.94 |
| Altman Z-Score | 1.43 |
SFOSF Number of Guru Trades
SFOSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SFOSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SFOSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
No Available Data
News about OTCPK:SFOSF
Total 0- 1